Form D · Biotechnology
KOLLTAN PHARMACEUTICALS INC
New Haven, CT · CIK 0001442835
Offering snapshot reported Mar 19, 2014 · SEC filing
- Reported sold
- $60M Offering amount: $60M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 13, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2014 | Initial | $60,000,000 | No comparison | 34 | SEC filing |
| Mar 7, 2012 | Initial | $25,000,000 | No comparison | 1 | SEC filing |
| Sep 16, 2010 | Amendment | $6,000,000 | $2,500,000vs Sep 8, 2009 | 1 | SEC filing |
| Jan 4, 2010 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Sep 8, 2009 | Initial | $3,500,000 | No comparison | 1 | SEC filing |
| Aug 12, 2009 | Amendment | $40,000,000 | No comparison | 54 | SEC filing |
| Aug 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213905
Source: Form D, filed Mar 19, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur G. Altschul, Jr. | Director |
| Axel Bolte | Director |
| Alex Bolte | Director |
| Stanley Choy | Executive |
| Yaron Hadari | Executive |
| Jane Pritchett Henderson | Executive |
| Peter Hirth | Director |
| K. Peter Hirth | Director |
| Theresa M. La Vallee | Executive |
| Gerald Mc Mahon | Director, Executive |
| Paul Medeiros | Director |
| W. Bradford Middlekauff | Executive |
| Thomas B. Neff | Director |
| Joseph Schlessinger | Director |
| Michael Schmertzler | Director, Executive |
| Carolyn F. Sidor | Executive |
| E. Jonathan Soderstrom | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
300 George Street Suite 530
New Haven, CT, 06511
New Haven, CT, 06511